Your browser doesn't support javascript.
loading
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.
Voss, Martin H; Hakimi, A Ari; Pham, Can G; Brannon, A Rose; Chen, Ying-Bei; Cunha, Luis F; Akin, Oguz; Liu, Han; Takeda, Shugaku; Scott, Sasinya N; Socci, Nicholas D; Viale, Agnes; Schultz, Nikolaus; Sander, Chris; Reuter, Victor E; Russo, Paul; Cheng, Emily H; Motzer, Robert J; Berger, Michael F; Hsieh, James J.
Afiliação
  • Voss MH; Authors' Affiliations: Departments of Medicine, Surgery, Pathology, Radiology, and Computational Biology; Human Oncology and Pathogenesis Program; Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center; and Department of Medicine, Weill Medical College of Cornell University, New York, New York.
Clin Cancer Res ; 20(7): 1955-64, 2014 Apr 01.
Article em En | MEDLINE | ID: mdl-24622468
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article